APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ceftriaxone Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ceftriaxone Injection Industry Growth and Trends Forecast to 2032

2 January 2026108 pages

Choose your research edition.

Industry ResearchCeftriaxone Injection Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Ceftriaxone Injection Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Ceftriaxone Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ceftriaxone Injection Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Ceftriaxone Injection Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Ceftriaxone Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ceftriaxone Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ceftriaxone Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ceftriaxone Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ceftriaxone Injection include ACS Dobfar, Aurobindo Pharma, Dawnrays, LKPC, Medya Pharma, NCPC, Nectar Lifesciences, Orchid Pharma and REYOUNG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ceftriaxone Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ceftriaxone Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ceftriaxone Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ceftriaxone Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Ceftriaxone Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ceftriaxone Injection Market by Company

ACS Dobfar

Aurobindo Pharma

Dawnrays

LKPC

Medya Pharma

NCPC

Nectar Lifesciences

Orchid Pharma

REYOUNG

United Laboratories

Kelun

Qilu Antibiotics

Shandong Ruiying

Ceftriaxone Injection Segment by Type

Single Injection

Compound Injection

Ceftriaxone Injection Segment by Application

Hospital

Clinic

Ceftriaxone Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ceftriaxone Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ceftriaxone Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ceftriaxone Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ceftriaxone Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Ceftriaxone Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Single Injection Table 2. Major Company of Compound Injection Table 3. Global Ceftriaxone Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Ceftriaxone Injection Sales by Type (2021-2026) & (K Units) Table 5. Global Ceftriaxone Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Ceftriaxone Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Ceftriaxone Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Ceftriaxone Injection Price by Type (2021-2026) & (US$/Unit) Table 9. Global Ceftriaxone Injection Sales by Type (2027-2032) & (K Units) Table 10. Global Ceftriaxone Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Ceftriaxone Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Ceftriaxone Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Ceftriaxone Injection Price by Type (2027-2032) & (US$/Unit) Table 14. North America Ceftriaxone Injection Sales by Type (2021-2026) & (K Units) Table 15. North America Ceftriaxone Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Ceftriaxone Injection Sales by Type (2021-2026) & (K Units) Table 17. Europe Ceftriaxone Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Ceftriaxone Injection Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Ceftriaxone Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Ceftriaxone Injection Sales by Type (2021-2026) & (K Units) Table 21. Latin America Ceftriaxone Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Ceftriaxone Injection Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Ceftriaxone Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Ceftriaxone Injection Industry Trends Table 25. Ceftriaxone Injection Industry Drivers Table 26. Ceftriaxone Injection Industry Opportunities and Challenges Table 27. Ceftriaxone Injection Industry Restraints Table 28. Global Ceftriaxone Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Ceftriaxone Injection Revenue Market Share by Company (2021-2026) Table 30. Global Ceftriaxone Injection Sales by Company (2021-2026) & (K Units) Table 31. Global Ceftriaxone Injection Sales Share by Company (2021-2026) Table 32. Global Ceftriaxone Injection Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Ceftriaxone Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Ceftriaxone Injection Major Company Production Sites and Headquarters Table 35. Global Ceftriaxone Injection Company, Product Type & Application Table 36. Global Ceftriaxone Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Ceftriaxone Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Ceftriaxone Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Ceftriaxone Injection Sales by Region (2021-2026) & (K Units) Table 41. Global Ceftriaxone Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Ceftriaxone Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Ceftriaxone Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Ceftriaxone Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Ceftriaxone Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Ceftriaxone Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Ceftriaxone Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Ceftriaxone Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Ceftriaxone Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Ceftriaxone Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Ceftriaxone Injection Sales by Application (2021-2026) & (K Units) Table 52. Global Ceftriaxone Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Ceftriaxone Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Ceftriaxone Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Ceftriaxone Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Ceftriaxone Injection Sales by Application (2027-2032) & (K Units) Table 57. Global Ceftriaxone Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Ceftriaxone Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Ceftriaxone Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Ceftriaxone Injection Price by Application (2027-2032) & (US$/Unit) Table 61. North America Ceftriaxone Injection Sales by Application (2021-2026) & (K Units) Table 62. North America Ceftriaxone Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Ceftriaxone Injection Sales by Application (2021-2026) & (K Units) Table 64. Europe Ceftriaxone Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Ceftriaxone Injection Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Ceftriaxone Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Ceftriaxone Injection Sales by Application (2021-2026) & (K Units) Table 68. Latin America Ceftriaxone Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Ceftriaxone Injection Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Ceftriaxone Injection Sales by Application (2021-2026) & (US$ Million) Table 71. ACS Dobfar Company Information Table 72. ACS Dobfar Business Overview Table 73. ACS Dobfar Ceftriaxone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. ACS Dobfar Ceftriaxone Injection Product Portfolio Table 75. ACS Dobfar Recent Development Table 76. Aurobindo Pharma Company Information Table 77. Aurobindo Pharma Business Overview Table 78. Aurobindo Pharma Ceftriaxone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Aurobindo Pharma Ceftriaxone Injection Product Portfolio Table 80. Aurobindo Pharma Recent Development Table 81. Dawnrays Company Information Table 82. Dawnrays Business Overview Table 83. Dawnrays Ceftriaxone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Dawnrays Ceftriaxone Injection Product Portfolio Table 85. Dawnrays Recent Development Table 86. LKPC Company Information Table 87. LKPC Business Overview Table 88. LKPC Ceftriaxone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. LKPC Ceftriaxone Injection Product Portfolio Table 90. LKPC Recent Development Table 91. Medya Pharma Company Information Table 92. Medya Pharma Business Overview Table 93. Medya Pharma Ceftriaxone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Medya Pharma Ceftriaxone Injection Product Portfolio Table 95. Medya Pharma Recent Development Table 96. NCPC Company Information Table 97. NCPC Business Overview Table 98. NCPC Ceftriaxone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. NCPC Ceftriaxone Injection Product Portfolio Table 100. NCPC Recent Development Table 101. Nectar Lifesciences Company Information Table 102. Nectar Lifesciences Business Overview Table 103. Nectar Lifesciences Ceftriaxone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Nectar Lifesciences Ceftriaxone Injection Product Portfolio Table 105. Nectar Lifesciences Recent Development Table 106. Orchid Pharma Company Information Table 107. Orchid Pharma Business Overview Table 108. Orchid Pharma Ceftriaxone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Orchid Pharma Ceftriaxone Injection Product Portfolio Table 110. Orchid Pharma Recent Development Table 111. REYOUNG Company Information Table 112. REYOUNG Business Overview Table 113. REYOUNG Ceftriaxone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. REYOUNG Ceftriaxone Injection Product Portfolio Table 115. REYOUNG Recent Development Table 116. United Laboratories Company Information Table 117. United Laboratories Business Overview Table 118. United Laboratories Ceftriaxone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. United Laboratories Ceftriaxone Injection Product Portfolio Table 120. United Laboratories Recent Development Table 121. Kelun Company Information Table 122. Kelun Business Overview Table 123. Kelun Ceftriaxone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Kelun Ceftriaxone Injection Product Portfolio Table 125. Kelun Recent Development Table 126. Qilu Antibiotics Company Information Table 127. Qilu Antibiotics Business Overview Table 128. Qilu Antibiotics Ceftriaxone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Qilu Antibiotics Ceftriaxone Injection Product Portfolio Table 130. Qilu Antibiotics Recent Development Table 131. Shandong Ruiying Company Information Table 132. Shandong Ruiying Business Overview Table 133. Shandong Ruiying Ceftriaxone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Shandong Ruiying Ceftriaxone Injection Product Portfolio Table 135. Shandong Ruiying Recent Development Table 136. North America Ceftriaxone Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. North America Ceftriaxone Injection Sales by Country (2021-2026) & (K Units) Table 138. North America Ceftriaxone Injection Sales Market Share by Country (2021-2026) Table 139. North America Ceftriaxone Injection Sales Forecast by Country (2027-2032) & (K Units) Table 140. North America Ceftriaxone Injection Sales Market Share Forecast by Country (2027-2032) Table 141. North America Ceftriaxone Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Ceftriaxone Injection Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Ceftriaxone Injection Market Share by Country (2021-2026) Table 144. North America Ceftriaxone Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Ceftriaxone Injection Market Share Forecast by Country (2027-2032) Table 146. Europe Ceftriaxone Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Europe Ceftriaxone Injection Sales by Country (2021-2026) & (K Units) Table 148. Europe Ceftriaxone Injection Sales Market Share by Country (2021-2026) Table 149. Europe Ceftriaxone Injection Sales Forecast by Country (2027-2032) & (K Units) Table 150. Europe Ceftriaxone Injection Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Ceftriaxone Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Ceftriaxone Injection Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Ceftriaxone Injection Market Share by Country (2021-2026) Table 154. Europe Ceftriaxone Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Ceftriaxone Injection Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Ceftriaxone Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Ceftriaxone Injection Sales by Country (2021-2026) & (K Units) Table 158. Asia-Pacific Ceftriaxone Injection Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Ceftriaxone Injection Sales Forecast by Country (2027-2032) & (K Units) Table 160. Asia-Pacific Ceftriaxone Injection Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Ceftriaxone Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Ceftriaxone Injection Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Ceftriaxone Injection Market Share by Country (2021-2026) Table 164. Asia-Pacific Ceftriaxone Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Ceftriaxone Injection Market Share Forecast by Country (2027-2032) Table 166. Latin America Ceftriaxone Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Latin America Ceftriaxone Injection Sales by Country (2021-2026) & (K Units) Table 168. Latin America Ceftriaxone Injection Sales Market Share by Country (2021-2026) Table 169. Latin America Ceftriaxone Injection Sales Forecast by Country (2027-2032) & (K Units) Table 170. Latin America Ceftriaxone Injection Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Ceftriaxone Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Ceftriaxone Injection Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Ceftriaxone Injection Market Share by Country (2021-2026) Table 174. Latin America Ceftriaxone Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Ceftriaxone Injection Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Ceftriaxone Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Ceftriaxone Injection Sales by Country (2021-2026) & (K Units) Table 178. Middle East and Africa Ceftriaxone Injection Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Ceftriaxone Injection Sales Forecast by Country (2027-2032) & (K Units) Table 180. Middle East and Africa Ceftriaxone Injection Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Ceftriaxone Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Ceftriaxone Injection Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Ceftriaxone Injection Market Share by Country (2021-2026) Table 184. Middle East and Africa Ceftriaxone Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Ceftriaxone Injection Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Ceftriaxone Injection Distributors List Table 189. Ceftriaxone Injection Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Ceftriaxone Injection Image Figure 2. Global Ceftriaxone Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ceftriaxone Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Ceftriaxone Injection Sales (2021-2032) & (K Units) Figure 5. Single Injection Image Figure 6. Global Single Injection Sales YoY Growth (2021-2032) & (K Units) Figure 7. Compound Injection Image Figure 8. Global Compound Injection Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Ceftriaxone Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Ceftriaxone Injection Market Share by Type 2025 VS 2032 Figure 11. North America Ceftriaxone Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Ceftriaxone Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Ceftriaxone Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Ceftriaxone Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Ceftriaxone Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Ceftriaxone Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Ceftriaxone Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Ceftriaxone Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Ceftriaxone Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Ceftriaxone Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Ceftriaxone Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Ceftriaxone Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Ceftriaxone Injection Market Share by Application 2025 VS 2032 Figure 29. North America Ceftriaxone Injection Sales Market Share in Volume by Application in 2025 Figure 30. North America Ceftriaxone Injection Sales Market Share in Value by Application in 2025 Figure 31. Europe Ceftriaxone Injection Sales Market Share in Volume by Application in 2025 Figure 32. Europe Ceftriaxone Injection Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Ceftriaxone Injection Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Ceftriaxone Injection Sales Market Share in Value by Application in 2025 Figure 35. Latin America Ceftriaxone Injection Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Ceftriaxone Injection Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Ceftriaxone Injection Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Ceftriaxone Injection Sales Market Share in Value by Application in 2025 Figure 39. North America Ceftriaxone Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Ceftriaxone Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Ceftriaxone Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Ceftriaxone Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Ceftriaxone Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Ceftriaxone Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Ceftriaxone Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Ceftriaxone Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Ceftriaxone Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Ceftriaxone Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Ceftriaxone Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Ceftriaxone Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Ceftriaxone Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Ceftriaxone Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Ceftriaxone Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Ceftriaxone Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Ceftriaxone Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Ceftriaxone Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Ceftriaxone Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Ceftriaxone Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Ceftriaxone Injection Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Ceftriaxone Injection Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Single Injection
  • Compound Injection
Applications
  • Hospital
  • Clinic
Companies covered
  • ACS Dobfar
  • Aurobindo Pharma
  • Dawnrays
  • LKPC
  • Medya Pharma
  • NCPC
  • Nectar Lifesciences
  • Orchid Pharma
  • REYOUNG
  • United Laboratories
  • Kelun
  • Qilu Antibiotics
  • Shandong Ruiying

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ceftriaxone Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Ceftriaxone Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Ceftriaxone Injection Market by Type
  6. 1.3.1 Single Injection
  7. 1.3.2 Compound Injection
  8. 1.4 Global Ceftriaxone Injection Market Size by Type
  9. 1.4.1 Global Ceftriaxone Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Ceftriaxone Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Ceftriaxone Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Ceftriaxone Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Ceftriaxone Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Ceftriaxone Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Ceftriaxone Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Ceftriaxone Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Ceftriaxone Injection Industry Trends
  2. 2.2 Ceftriaxone Injection Industry Drivers
  3. 2.3 Ceftriaxone Injection Industry Opportunities and Challenges
  4. 2.4 Ceftriaxone Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Ceftriaxone Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Ceftriaxone Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Ceftriaxone Injection Price (2021-2026)
  4. 3.4 Global Ceftriaxone Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ceftriaxone Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Ceftriaxone Injection Company, Product Type & Application
  7. 3.7 Global Ceftriaxone Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ceftriaxone Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ceftriaxone Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ceftriaxone Injection Tier 1, Tier 2, and Tier 3
4 Ceftriaxone Injection Regional Status and Outlook
  1. 4.1 Global Ceftriaxone Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Ceftriaxone Injection Historic Market Size by Region
  3. 4.2.1 Global Ceftriaxone Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Ceftriaxone Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Ceftriaxone Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Ceftriaxone Injection Forecasted Market Size by Region
  7. 4.3.1 Global Ceftriaxone Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Ceftriaxone Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Ceftriaxone Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ceftriaxone Injection by Application
  1. 5.1 Ceftriaxone Injection Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Ceftriaxone Injection Market Size by Application
  5. 5.2.1 Global Ceftriaxone Injection Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Ceftriaxone Injection Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Ceftriaxone Injection Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Ceftriaxone Injection Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Ceftriaxone Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Ceftriaxone Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Ceftriaxone Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Ceftriaxone Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 ACS Dobfar
  2. 6.1.1 ACS Dobfar Company Information
  3. 6.1.2 ACS Dobfar Business Overview
  4. 6.1.3 ACS Dobfar Ceftriaxone Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 ACS Dobfar Ceftriaxone Injection Product Portfolio
  6. 6.1.5 ACS Dobfar Recent Developments
  7. 6.2 Aurobindo Pharma
  8. 6.2.1 Aurobindo Pharma Company Information
  9. 6.2.2 Aurobindo Pharma Business Overview
  10. 6.2.3 Aurobindo Pharma Ceftriaxone Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Aurobindo Pharma Ceftriaxone Injection Product Portfolio
  12. 6.2.5 Aurobindo Pharma Recent Developments
  13. 6.3 Dawnrays
  14. 6.3.1 Dawnrays Company Information
  15. 6.3.2 Dawnrays Business Overview
  16. 6.3.3 Dawnrays Ceftriaxone Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Dawnrays Ceftriaxone Injection Product Portfolio
  18. 6.3.5 Dawnrays Recent Developments
  19. 6.4 LKPC
  20. 6.4.1 LKPC Company Information
  21. 6.4.2 LKPC Business Overview
  22. 6.4.3 LKPC Ceftriaxone Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 LKPC Ceftriaxone Injection Product Portfolio
  24. 6.4.5 LKPC Recent Developments
  25. 6.5 Medya Pharma
  26. 6.5.1 Medya Pharma Company Information
  27. 6.5.2 Medya Pharma Business Overview
  28. 6.5.3 Medya Pharma Ceftriaxone Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Medya Pharma Ceftriaxone Injection Product Portfolio
  30. 6.5.5 Medya Pharma Recent Developments
  31. 6.6 NCPC
  32. 6.6.1 NCPC Company Information
  33. 6.6.2 NCPC Business Overview
  34. 6.6.3 NCPC Ceftriaxone Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 NCPC Ceftriaxone Injection Product Portfolio
  36. 6.6.5 NCPC Recent Developments
  37. 6.7 Nectar Lifesciences
  38. 6.7.1 Nectar Lifesciences Company Information
  39. 6.7.2 Nectar Lifesciences Business Overview
  40. 6.7.3 Nectar Lifesciences Ceftriaxone Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Nectar Lifesciences Ceftriaxone Injection Product Portfolio
  42. 6.7.5 Nectar Lifesciences Recent Developments
  43. 6.8 Orchid Pharma
  44. 6.8.1 Orchid Pharma Company Information
  45. 6.8.2 Orchid Pharma Business Overview
  46. 6.8.3 Orchid Pharma Ceftriaxone Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Orchid Pharma Ceftriaxone Injection Product Portfolio
  48. 6.8.5 Orchid Pharma Recent Developments
  49. 6.9 REYOUNG
  50. 6.9.1 REYOUNG Company Information
  51. 6.9.2 REYOUNG Business Overview
  52. 6.9.3 REYOUNG Ceftriaxone Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 REYOUNG Ceftriaxone Injection Product Portfolio
  54. 6.9.5 REYOUNG Recent Developments
  55. 6.10 United Laboratories
  56. 6.10.1 United Laboratories Company Information
  57. 6.10.2 United Laboratories Business Overview
  58. 6.10.3 United Laboratories Ceftriaxone Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 United Laboratories Ceftriaxone Injection Product Portfolio
  60. 6.10.5 United Laboratories Recent Developments
  61. 6.11 Kelun
  62. 6.11.1 Kelun Company Information
  63. 6.11.2 Kelun Business Overview
  64. 6.11.3 Kelun Ceftriaxone Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Kelun Ceftriaxone Injection Product Portfolio
  66. 6.11.5 Kelun Recent Developments
  67. 6.12 Qilu Antibiotics
  68. 6.12.1 Qilu Antibiotics Company Information
  69. 6.12.2 Qilu Antibiotics Business Overview
  70. 6.12.3 Qilu Antibiotics Ceftriaxone Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Qilu Antibiotics Ceftriaxone Injection Product Portfolio
  72. 6.12.5 Qilu Antibiotics Recent Developments
  73. 6.13 Shandong Ruiying
  74. 6.13.1 Shandong Ruiying Company Information
  75. 6.13.2 Shandong Ruiying Business Overview
  76. 6.13.3 Shandong Ruiying Ceftriaxone Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Shandong Ruiying Ceftriaxone Injection Product Portfolio
  78. 6.13.5 Shandong Ruiying Recent Developments
7 North America by Country
  1. 7.1 North America Ceftriaxone Injection Sales by Country
  2. 7.1.1 North America Ceftriaxone Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Ceftriaxone Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Ceftriaxone Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Ceftriaxone Injection Market Size by Country
  6. 7.2.1 North America Ceftriaxone Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Ceftriaxone Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Ceftriaxone Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Ceftriaxone Injection Sales by Country
  2. 8.1.1 Europe Ceftriaxone Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Ceftriaxone Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Ceftriaxone Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Ceftriaxone Injection Market Size by Country
  6. 8.2.1 Europe Ceftriaxone Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Ceftriaxone Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Ceftriaxone Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Ceftriaxone Injection Sales by Country
  2. 9.1.1 Asia-Pacific Ceftriaxone Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Ceftriaxone Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Ceftriaxone Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Ceftriaxone Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Ceftriaxone Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Ceftriaxone Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Ceftriaxone Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Ceftriaxone Injection Sales by Country
  2. 10.1.1 South America Ceftriaxone Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Ceftriaxone Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Ceftriaxone Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Ceftriaxone Injection Market Size by Country
  6. 10.2.1 South America Ceftriaxone Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Ceftriaxone Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Ceftriaxone Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Ceftriaxone Injection Sales by Country
  2. 11.1.1 Middle East and Africa Ceftriaxone Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Ceftriaxone Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Ceftriaxone Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Ceftriaxone Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Ceftriaxone Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Ceftriaxone Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Ceftriaxone Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Ceftriaxone Injection Value Chain Analysis
  2. 12.1.1 Ceftriaxone Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Ceftriaxone Injection Production Mode & Process
  7. 12.2 Ceftriaxone Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Ceftriaxone Injection Distributors
  10. 12.2.3 Ceftriaxone Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst